Monday Nov 24, 2008 (foodconsumer.org) -- A drug
vanadium-allixin compound when administered orally lowers blood glucose levels
in diabetic mice, according to a new study in the Jan 2009 issue of the Royal
Society of Chemistry journal Metallomics.
Hiromu Sakurai and colleagues from the Suzuka University
of Medical Science, Japan found allixin found the drug based on vanadium and allixin,
a compound found in garlic, when given orally to type I diabetic mice reduced
blood glucose levels.
In previous studies, the researchers have discovered the
vanadium-allixin compound treated both type 1 and type 2 diabetes when
injected, but this new study shows oral treatment with this drug is also
Type 1 diabetes (insulin dependent) requires daily injections
of insulin and type 2 diabetes (non-insulin dependent) is treated with drugs,
but none of which is ideal, according to the researchers.
Human trials are needed to confirm the efficacy and safety of this drug.
Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only.
The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals.
Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.